Authors
CE Lloyd, A Nouwen, N Sartorius, HU Ahmed, A Alvarez, S Bahendeka, D Basangwa, AE Bobrov, S Boden, V Bulgari, L Burti, SK Chaturvedi, LC Cimino, W Gaebel, G De Girolamo, TM Gondek, M Guinzbourg de Braude, A Guntupalli, MG Heinze, L Ji, X Hong, A Khan, A Kiejna, A Kokoszka, T Kamala, NM Lalic, D Lecic Tosevski, B Mankovsky, M Li, A Musau, K Müssig, D Ndetei, G Rabbani, SS Srikanta, EG Starostina, M Shevchuk, R Taj, O Vukovic, W Wölwer, Y Xin
Publication date
2018/6
Journal
Diabetic Medicine
Volume
35
Issue
6
Pages
760-769
Description
Aims
To assess the prevalence and management of depressive disorders in people with Type 2 diabetes in different countries.
Methods
People with diabetes aged 18–65 years and treated in outpatient settings were recruited in 14 countries and underwent a psychiatric interview. Participants completed the Patient Health Questionnaire and the Problem Areas in Diabetes scale. Demographic and medical record data were collected.
Results
A total of 2783 people with Type 2 diabetes (45.3% men, mean duration of diabetes 8.8 years) participated. Overall, 10.6% were diagnosed with current major depressive disorder and 17.0% reported moderate to severe levels of depressive symptomatology (Patient Health Questionnaire scores >9). Multivariable analyses showed that, after controlling for country, current major depressive disorder was significantly associated with gender (women) (P<0.0001), a lower level of …
Scholar articles
CE Lloyd, A Nouwen, N Sartorius, HU Ahmed… - Diabetic Medicine, 2018